crm12Comb

cranv0.1.12

Phase I/II CRM Based Drug Combination Design. Implements the adaptive designs for integrated phase I/II trials of drug combinations via continual reassessment method (CRM) to evaluate toxicity and efficacy simultaneously for each enrolled patient cohort based on Bayesian inference. It supports patients assignment guidance in a single trial usin

License GPL (>= 3)0 versions1 maintainers3 deps64 weekly dl
https://CRAN.R-project.org/package=crm12Comb
47
/ 100
Health
safe to use

[email protected] is safe to use (health: 47/100)

Health breakdown0 – 100
20/25
maintenance
0/20
popularity
25/25
security
0/15
maturity
2/15
community
Vulnerabilities
0
none known

Health History

Dependency Tree

License Audit

Dependencies (3)
dplyrggplot2ggforce
API access

Get this data programmatically — free, no authentication.

curl https://depscope.dev/api/check/cran/crm12Comb

First published · 2026-02-03 09:23:05

Last updated · 2026-02-03T07:30:08+00:00